Fluid, electrolyte, and acid-base disturbances in liver disease

Fluid, Electrolyte and Acid-Base Disorders in Small Animal Practice

Volumn , Issue , 2006, Pages 437-477

  Center, Sharon A ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78649244755     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-72-163949-6/50022-9     Document Type: Chapter

References (183)

1. Aberg M, Hedner V, Bergentz S Effect of dextran on factor VIII and platelet function. Ann Surg 1979, 189:243-247.
2. Aberg M, Bergentz S, Hedner U Effect of dextran and induced thrombocytopenia on the lysability of ex vivo thrombi in dogs. Acta Chir Scand 1977, 143:91-94.
3. Abraldes JG, Bosch J Somatostatin and analogues in portal hypertension. Hepatology 2002, 35:1305-1311.
4. Ackermann D, Vogt B, Escher G, et al. Inhibition of 11β-hydroxysteroid dehydrogenase by bile acids in rats with cirrhosis. Hepatology 1999, 30:623-629.
5. Adrogue HJ, Tannen RL Ketoacidosis, hyperosmolar states, and lactic acidosis. Fluids and Electrolytes 1996, 643-674. WB Saunders, Philadelphia. ed 3. J.P. Kokko, R.L. Tannen (Eds.).
6. Aizawa Y, Ohmori T, Imai K, et al. Depressant action of acetate upon the human cardiovascular system. Clin Nephrol 1977, 8:477-480.
7. Amatuzio DS, Nesbitt S A study of pyruvic acid in the blood, spinal fluid and urine of patients with liver disease with and without hepatic coma. Clin Invest 1950, 29:1486-1490.
8. Angeli P, Volpin R, Gerunda G, et al. Reversal of type 1 hepatorenal syndrome with administration of midodrine and octreotide. Hepatology 1999, 29:1690-1697.
9. Arai K, Kawamoto M, Yuge O, et al. A comparative study of lactated Ringer and acetated Ringer solution as intraoperative fluids in patients with liver dysfunction. Masui 1986, 35:793-799.
10. Angeli P Prognosis of hepatorenal syndrome: has it changed with current practice?. Aliment Pharmacol Ther 2004, 20(suppl 3):44-48.
11. Arieff AI, Park R, Leach J, et al. Pathophysiology of experimental lactic acidosis in dogs. Am J Physiol 1980, 239:F135-F142.
12. Arroyo V, Gines P, Planas R Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis. Gastroenterol Clin North Am 1992, 21:237-256.
13. Arroyo V, Rodes J, Gutierrez-Lizarraga MA, et al. Prognostic value of spontaneous hyponatremia in cirrhosis with ascites. Am J Dig Dis 1976, 21:249-256.
14. Baumann H, Gauldie J The acute phase response. Immunol Today 1994, 15:74-80.
15. Bergqvist D Dextrans and haemostasis: a review. Acta Chir Scand 1982, 31:320-324.
16. Bernardi M Renal sodium retention in preascitic cirrhosis: expanding knowledge, enduring uncertainties. Hepatology 2002, 35:1544-1547.
17. Bernat A, Hoffmann P, Dumas A, et al. V2 receptor antagonism of DDAVP-induced release of hemostasis factors in conscious dogs. J Pharmacol Exp Ther 1997, 282:597-602.
18. Better OS, Schrier RW Disturbed volume homeostasis in patients with cirrhosis of the liver. Kidney Int 1983, 23:303-309.
19. Bienzle D, Jacobs RM, Lumsden JH Relationship of serum total calcium to serum albumin in dogs, cats, horses and cattle. Can Vet J 1993, 34:360-364.
20. Bihari D, Gimson AE, Waterson M, et al. Tissue hypoxia during fulminant hepatic failure. Crit Care Med 1985, 13:1034-1039.
21. Bihari D, Smithies M, Gimson A, et al. The effects of vasodilation with prostacyclin on oxygen delivery and uptake in critically ill patients. N Engl J Med 1987, 317:397-403.
22. Boron VF, Hediger MA, Boulpaep EL, et al. The renal electrogenic Na+:HCO3-cotransporter. J Exp Biol 1997, 200:263-268.
23. Brenner DA, Buck M, Feitelberg SP, et al. Tumor necrosis factor-alpha inhibits albumin gene expression in a murine model of cachexia. J Clin Invest 1990, 85:248-255.
24. Brown SA, Spyridakis LK, Crowell WA Distal renal tubular acidosis and hepatic lipidosis in a cat. J Am Vet Med Assoc 1986, 189:1350-1352.
25. Caregaro L, Menon F, Angeli P, et al. Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. Arch Intern Med 1994, 154:201-205.
26. Casey TH, Summerskill WHJ, Bickford RG, et al. Body and serum potassium in liver disease: II. Relationships to arterial ammonia, blood pH, and hepatic coma. Gastroenterology 1965, 48:208-215.
27. Castell JV, Gomez-Lechon MJ, David M, et al. Acute-phase protein synthesis by interleukin-6. Hepatology 1990, 12:1179-1186.
28. Center SA, Crawford MA, Guida L, et al. A retrospective study of cats (n=77) with severe hepatic lipidosis: (1975-1990). J Vet Intern Med 1993, 7:349-359.
29. Center SA, Magne M Historical, physical examination, and clinicopathologic features of portosystemic vascular anomalies in the dog and cat. Sem Vet Med Surg Small Anim 1990, 5:83-93.
30. Center SA, Warner K, Corbett J, et al. Proteins invoked by vitamin K absence and clotting times in clinically ill cats. J Vet Intern Med 2000, 14:292-297.
31. Center SA Unpublished observations 2005, College of Veterinary Medicine, Cornell University.
32. Center SA Feline hepatic lipidosis. Vet Clin North Am Small Anim Pract 2005, 35:225-269.
33. Center SA, Thompson M, Wood PA, et al: Hepatic ultrastructural and metabolic derangements in cats with severe hepatic lipidosis. Proceedings of the 9th ACVIM Forum, 1991, pp. 193-196.
34. Center SA Nutritional support for dogs and cats with hepatobiliary disease. J Nutr 1998, 128:2733S-2746S.
35. Center SA Pathophysiology of liver disease: normal and abnormal function. Strombeck's small animal gastroenterology 1996, 553-632. WB Saunders, Philadelphia. ed 3. G.A. Guilford, S.A. Center, D.R. Strombeck (Eds.).
36. Chung C, Vaquero J, Gottstein J, et al. Vasopressin accelerates experimental ammonia-induced brain edema in rats after portocaval anastomosis. J Hepatol 2003, 39:193-199.
37. Cochrane Injuries Group Albumin Reviewers Human albumin administration in critically ill patients: systematic review of randomized controlled trials. BMJ 1998, 317:235-239.
38. Cohen RD, Iles RA, Barnett D, et al. The effect of changes in lactate uptake on the intracellular pH of the perfused rat liver. Clin Sci 1971, 41:159-170.
39. Concannon KT, Haskins S, Feldman BF Hemostatic defects associated with two infusion rates of dextran 70 in dogs. Am J Vet Res 1992, 53:1369-1375.
40. Cooper AJL Role of the liver in amino acid metabolism. Hepatology: a textbook of liver disease 1996, 563-604. WB Saunders, Philadelphia. ed 3. D. Zakim, T.D. Boyer (Eds.).
41. Cotrim HP, Garrido V, Parana R, et al. Paracentesis associated with dextran-70 in the treatment of ascites in patients with chronic liver diseases: a randomized therapeutic study. Arq Gastroenterol 1994, 31:125-129.
42. Craddock PR, Yawata Y, VanSanten L, et al. Acquired phagocyte dysfunction: a complication of hypophosphatemia of parenteral hyperalimentation. N Engl J Med 1974, 290:1403-1407.
43. Davit-Spraul A, Cosson C, Couturier M, et al. Standard treatment of alpha-tocopherol in Alagille patients with severe cholestasis is insufficient. Pediatr Res 2001, 49:232-236.
44. Damon L, Adams M, Stricker R, et al. Intracranial bleeding during treatment with hydroxyethyl starch. N Engl J Med 1987, 317:964-965.
45. Dalrymple-Hay M, Aitchison R, Collins P, et al. Hydroxyethyl starch induced acquired von Willebrand's disease. Clin Lab Haematol 1992, 14:209-211.
46. DeGasperi A, Mazz E, Corti A, et al. Lactate blood levels in the perioperative period of orthotopic liver transplantation. Int J Clin Lab Res 1997, 27:123-128.
47. Deppe TA, Center SA, Simpson KW, et al. Glomerular filtration rate and renal volume in dogs with congenital portosystemic vascular anomalies before and after surgical ligation. J Vet Intern Med 1999, 13:465-471.
48. Dich J, Hansen SE, Thieden HID Effect of albumin concentration and colloid osmotic pressure on albumin synthesis in perfused rat liver. Acta Physiol Scand 1973, 89:352-358.
49. Dillingham MA, Anderson RJ Electrolyte, water, mineral, and acid base disorders in liver disease. Clinical disorders of fluid and electrolyte metabolism 1987, 879-896. McGraw-Hill, New York, New York. ed 4. M.H. Maxwell, C.R. Kleeman, R.G. Narins (Eds.).
50. Dixon FJ, Maurer PH, Deichmiller MP Half-lives of homologous serum albumins in several species. Soc Exp Bio Med 1953, 83:287-288.
51. Dubick MA, Zaucha GM, Korte DW, et al. Acute and subacute toxicity of 7.5% hypertonic saline-6% dextran-70 (HSD) in dogs. 2. Biochemical and behavioral responses. J Appl Toxicol 1993, 13:49-55.
52. Emmitt M, Narins RG Mixed acid-base disorders. Clinical disorders of fluid and electrolyte metabolism 1987, 743-788. McGraw-Hill, New York. ed 4. M.H. Maxwell, C.R. Kleeman, R.G. Narins (Eds.).
53. Epstein M Atrial natriuretic factor and liver disease. The kidney in liver disease 1996, 339-358. Hanley & Belfus Inc., Philadelphia. ed 4. M. Epstein (Ed.).
54. Epstein M Derangements of renal water handling in liver disease. Gastroenterology 1985, 89:1415-1425.
55. Erlinger S Physiology of bile secretion and enterohepatic circulation. Physiology of the gastrointestinal tract 1987, 1557-1580. Raven Press, New York. ed 2. L.R. Johnson (Ed.).
56. Evans TW Review article: albumin as a drug-biological effects of albumin unrelated to oncotic pressure. Aliment Pharmacol Ther 2002, 16(suppl 5):6-11.
57. Fassio E, Terg R, Landeira G, et al. Paracentesis with Dextran 70 vs paracentesis with albumin in cirrhosis with tense ascites. Results of a randomized study. J Hepatol 1992, 14:310-316.
58. Fink RM, Enns R, Kimball CP, et al. Plasma protein metabolism: observations using heavy nitrogen in lysine. J Exp Med 1944, 80:455-475.
59. Flanders JA, Scarlett JM, Blue JT, et al. Adjustment of total serum calcium concentration for binding to albumin and protein in cats: 291 cases (1986-1987). J Am Vet Med Assoc 1989, 194:1609-1611.
60. Forrester SD, Moreland KJ Hypophosphatemia: causes and clinical consequences. J Vet Intern Med 1989, 3:149-159.
61. Francisco LL, Sawin LL, Dibona GF Mechanism of negative potassium balance in the magnesium-deficient rat. Proc Soc Exp Biol Med 1981, 168:382-388.
62. Frommer JP Lactic acidosis. Med Clin North Am 1983, 67:815-829.
63. Garzon AA, Cheng C, Lerner B, et al. Hydroxyethyl starch (HES) and bleeding: an experimental investigation of its effect on hemostasis. J Trauma 1967, 7:757-766.
64. Gerbes AL, Gulberg V, Gines P, et al. Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial. Gastroenterology 2003, 124:933-939.
65. Gines P, Berl T, Bernardi M, et al. Hyponatremia in cirrhosis: from pathogenesis to treatment. Hepatology 1998, 28:851-864.
66. Gollub S, Schaefer C, Squitieri A The bleeding tendency associated with plasma expanders. Surg Gynecol Obstet 1967, 124:1203-1211.
67. Good DW Effects of potassium on ammonia transport by medullary thick ascending limbs of the rat. J Clin Invest 1987, 80:1358-1365.
68. Grauer GF, Pitts RP Primary polydipsia in three dogs with portosystemic shunts. J Am Anim Hosp Assoc 1987, 23:197-200.
69. Graf H, Leach W, Arieff AI Metabolic effects of sodium bicarbonate in hypoxic lactic acidosis in dogs. Am J Physiol 1985, 249:F630-F635.
70. Harvey JW, West CL Prednisone-induced increases in serum alpha-2-globulin and haptoglobin concentrations in dogs. Vet Pathol 1987, 24:90-92.
71. Haupt MT, Rackow EC Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Crit Care Med 1982, 10:159-162.
72. Haussinger D, Kaiser S, Stehle T, et al. Liver carbonic anhydrase and urea synthesis. The effect of diuretics. Biochem Pharmacol 1986, 35:3317-3322.
73. Heinemann HO, Emirgil C, Mijnssen JP Hyperventilation and arterial hypoxemia in cirrhosis of the liver. Am J Med 1960, 28:239-246.
74. Heymsfield SB, Waki M, Reinus J Are patients with chronic liver disease hypermetabolic?. Hepatology 1990, 11:502-504.
75. Hoffenberg R Control of albumin degradation in vivo and in the perfused liver. Plasma protein metabolism: regulation of synthesis, distribution and degradation 1970, 239-255. Academic Press, New York. M.A. Rothschild, T. Waldmann (Eds.).
76. Hulse J, Yacobi A Hetastarch: an overview of the colloid and its metabolism. Drug Intel Clin Pharmacol 1983, 17:334-341.
77. Jalan R, Kapoor D Enhanced renal ammonia excretion following volume expansion in patients with well compensated cirrhosis of the liver. Gut 2003, 52:1041-1045.
78. Jeunesse E, Woehrle F, Schneider M, et al. Spironolactone as a diuretic agent in the dog: is the water becoming muddy (abstract). J Vet Intern Med 2004, 18:448.
79. Kanno N, LeSage G, Glaser S, et al. Regulation of cholangiocyte bicarbonate secretion. Am J Physiol 2001, 281:G612-G625.
80. Karlson KE, Garzon AA, Shaftan GW, et al. Increased blood loss associated with administration of certain plasma expanders: Dextran 75, Dextran 40, and hydroxyethyl starch. Surgery 1967, 62:670-678.
81. Kelly DA, Summerfield JA Hemostasis in liver disease. Semin Liver Dis 1987, 7:182-191.
82. Kirsch RF, Saunders SJ, Frith L, et al. Plasma amino acid-regulation of albumin synthesis. J Nutr 1969, 98:395-403.
83. Kiszka-Kanowitz M, Henriksen JH, Hansen EF, et al. Effect of terlipressin on blood volume distribution in patients with cirrhosis. Scand J Gastroenterol 2004, 5:486-492.
84. Knepper MA Molecular physiology of urinary concentrating mechanism: regulation of aquaporin water channels by vasopressin. Am J Physiol 1997, 272:F3-F12.
85. Koj A, Gauldie J, Regoeezi E, et al. The acute-phase response of cultured rat hepatocytes. Biochem J 1984, 224:505-514.
86. Kone BC, Higham SC A novel N-terminal splice variant of the rate H+-K+-ATPase α2 subunit. J Biol Chem 1998, 273:3543-3552.
87. Kozlowski S, Krzysztof D The role of osmoreception in portal circulation in control of water intake in dogs. Acta Physiol Pol 1973, 24:325-330.
88. Kreisberg RA Lactate homeostasis and lactic acidosis. Ann Intern Med 1980, 92:227-237.
89. - cotransporter in rabbits and normotensive rats but not in spontaneously hypertensive rats. Kidney Int 2000, 57:534-543.
90. Levy M, Wexler MJ Renal sodium retention and ascites formation in dogs with experimental cirrhosis but without portal hypertension or increased splanchnic vascular capacity. J Lab Clin Med 1978, 91:520-536.
91. Levy M Pathogenesis of sodium retention in early cirrhosis of the liver: evidence for vascular overfilling. Semin Liver Dis 1994, 14:4-13.
92. Levy M Sodium retention and ascites formation in dogs with experimental portal cirrhosis. Am J Physiol 1977, 233:F572-F585.
93. Levy M Sodium retention in dogs with cirrhosis and ascites: efferent mechanisms. Am J Physiol 1977, 233:F586-F592.
94. Lewis JH, Szeto IL, Bayer WL Severe hemodilution with hydroxyethyl starch and dextrans. Arch Surg 1966, 93:941-950.
95. Luft FC Lactic acidosis update for critical care clinicians. J Am Soc Nephrol 2001, 12:S15-S19.
96. Lunn PC, Austin S Excess energy intake promotes the development of hypoalbuminemia in rats fed on low-protein diets. Br J Nutr 1983, 49:9-16.
97. Macintyre E, Mackie IJ, Ho D, et al. The haemostatic effects of hydroxyethyl starch (HES) used as a volume expander. Intensive Care Med 1985, 11:300-303.
98. Margarson MP, Soni N Serum albumin: touchstone or totem?. Anaesthesia 1998, 53:789-803.
99. McAuliffe JJ, Lind LJ, Leith DE, et al. Hypoproteinemic alkalosis. Am J Med 1986, 81:86-90.
100. McCullough AJ, Mullen KD, Kalhan SC Measurements of total body and extracellular water in cirrhotic patients with and without ascites. Hepatology 1991, 14:1102-1111.
101. McGuire SO, Alexander DW, Fritsche KL Fish oil source differentially affects rat immune cell alpha-tocopherol concentration. J Nutr 1997, 127:1388-1394.
102. Meier PJ Molecular mechanisms of hepatic bile salt transport from sinusoidal blood into bile. Am J Physiol 1995, 269:G801-G812.
103. Meuten DJ, Chew DJ, Capen CC, et al. Relationship of serum total calcium to albumin and total protein in dogs. J Am Vet Med Assoc 1982, 180:63-67.
104. Mishler JM Pharmacology of hydroxyethyl starch. Use in therapy and blood banking 1982, 1-118. Oxford University Press, Oxford.
105. Moller S, Henriksen JH Pathogenesis and pathophysiology of hepatorenal syndrome-is there scope for prevention?. Aliment Pharmacol Ther 2004, 20(suppl 3):31-41.
106. Moore KP, Wong F, Gines P, et al. The management of ascites in cirrhosis: report on the consensus conference of the international ascites club. Hepatology 2003, 38:258-266.
107. Moore LE, Garvey MS The effect of hetastarch on serum colloid oncotic pressure in hypoalbuminemic dogs. J Vet Intern Med 1996, 10:300-303.
108. Morgan EH, Peters T The biosynthesis of rat serum albumin: V. Effect of protein depletion and refeeding on albumin and transferrin synthesis. J Biol Chem 1971, 246:3500-3507.
109. Moshage H Cytokines and the hepatic acute phase response. J Pathol 1997, 181:257-266.
110. Murphy GP, Demaree DE, Gagnon JA The renal and systemic effects of hydroxyethyl starch solution infusions. J Urol 1965, 93:534-539.
111. Moreau R, Hadengue A, Soupison T, et al. Arterial and mixed venous acid-base status in patients with cirrhosis. Influence of liver failure. Liver 1993, 13:20-24.
112. Nagami GT Effect of bath and luminal potassium concentration on ammonia production and secretion by mouse proximal tubules perfused in vitro. J Clin Invest 1990, 86:32-39.
113. Nelson DC, McGrew WRG, Hoyumpa AM Hypernatremia and lactulose therapy. JAMA 1983, 249:1295-1298.
114. Nyberg SL, Cerra FB, Gruetter R Brain lactate by magnetic resonance spectroscopy during fulminant hepatic failure in the dog. Liver Transpl Surg 1998, 4:158-165.
115. Olde Damink SWM, Jalan R, Deutz NE, et al. The kidney plays a major role in the hyperammonemia seen after simulated or actual GI bleeding in patients with cirrhosis. Hepatology 2003, 37:1277-1285.
116. Papadakis MA, Arieff AI Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study. Am J Med 1987, 82:945-953.
117. Papper S The role of the kidney in Laennec's cirrhosis of the liver. Medicine (Baltimore) 1958, 37:299-309.
118. Papper S, Belsky JL, Bleifer KH Renal failure in Laennec's cirrhosis of the liver. I. Description of the clinical and laboratory features. Ann Intern Med 1959, 51:759-765.
119. Papper S, Saxon L The diuretic response to administered water in patients with liver disease. II. Laennec's cirrhosis of the liver. Arch Intern Med 1959, 103:750-757.
120. Park R, Leach WJ, Arieff AI Determination of the liver intracellular pH in vivo and its homeostasis in acute acidosis and alkalosis. Am J Physiol 1979, 236:F240-F245.
121. Park R, Arieff AI Lactic acidosis. Adv Int Med 1980, 25:33-68.
122. Park R, Arieff AI, Leach W, et al. Treatment of lactic acidosis with dichloroacetate in dogs. J Clin Invest 1982, 70:853-862.
123. Parth E, Jurecka W, Szepfalusi Z Histological and immunohistochemical investigations of hydroxyethyl starch deposits in rat tissues. Eur Surg Res 1992, 24:13-21.
124. Pembleton-Corbett JR, Center SA, Schermerhorn T, et al. Serum-effusion albumin gradient in dogs with transudative abdominal effusion. J Vet Intern Med 2000, 14:613-618.
125. Perschel FH, Buhler H, Hierholzer K Bile acids and their amidates inhibit 11 beta-hydroxysteroid dehydrogenase obtained from rat kidney. Pflugers Arch 1991, 418:538-543.
126. Prytz H, Thomsen AC Acid-base status in liver cirrhosis. Disturbances in stable, terminal and porta-caval shunted patients. Scand J Gastroenterol 1976, 11:249-256.
127. Pugh P, Stone SL The ionic composition of bile. J Physiol 1969, 201:50P-51P.
128. Quinlan GJ, Margarson MP, Mumby S, et al. Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion. Clin Sci (Lond) 1998, 95:459-465.
129. Record CO, Iles RA, Cohen RD, et al. Acid-base and metabolic disturbances in fulminant hepatic failure. Gut 1975, 16:144-149.
130. Rothschild MA, Oratz M, Dessler R, et al. Albumin synthesis in cirrhotic subjects with ascites studied with carbonate 14. J Clin Invest 1969, 48:344-350.
131. Rothschild MA, Oratz M, Schreiber SS Serum albumin. Hepatology 1988, 8:385-401.
132. Rothuizen J, Biewenga WJ, Mol JA Chronic glucocorticoid excess and impaired osmoregulation of vasopressin release in dogs with hepatic encephalopathy. Domest Anim Endocrinol 1995, 12:13-24.
133. Rudloff E, Kirby R The critical need for colloids: selecting the right colloid. Compend Contin Educ 1997, 19:811-825.
134. Ruiz-del-Arbol L, Monescillo A, Jimenez W, et al. Paracentesis-induced circulatory dysfunction: mechanisms and effect on hepatic hemodynamics in cirrhosis. Gastroenterology 1997, 113:579-586.
135. Saner FH, Fruhauf NR, Schafers RF, et al. Terlipressin plus hydroxyethyl starch infusion: an effective treatment for hepatorenal syndrome. Eur J Gastroenterol Hepatol 2003, 15:925-927.
136. Sanfilippo MJ, Suberviola PD, Geimer NF Development of a von Willebrand-like syndrome after prolonged use of hydroxyethyl starch. Am J Clin Pathol 1987, 88:653-655.
137. Schenker S, Breen KJ, Hoyumpa AM Hepatic encephalopathy: current status. Gastroenterology 1974, 66:121-151.
138. Sebastian A, Sutton JM, Hulter HM, et al. Effect of mineralocorticoid replacement therapy on renal acid-base homeostasis in adrenalectomized patients. Kidney Int 1980, 18:762-763.
139. Sevelius E, Andersson M Serum protein electrophoresis as a prognostic marker of chronic liver disease in dogs. Vet Rec 1995, 137:663-667.
140. Shangraw RE, Jahoor F Effect of liver disease and transplantation on urea synthesis in humans: relationship to acid-base status. Am J Physiol 1999, 276:G1145-G1152.
141. Shear L, Kleinerman J, Gabuzda GJ Renal failure in patients with cirrhosis of the liver. I. Clinical and pathologic characteristics. Am J Med 1965, 39:184-189.
142. 12) in cats with gastrointestinal disease. J Vet Intern Med 2001, 15:26-32.
143. Smiley LE, Garvey MS The use of hetastarch as adjunct therapy in 26 dogs with hypoalbuminemia: a phase two clinical trial. J Vet Intern Med 1994, 8:195-202.
144. Sokol RJ, Devereaux M, Khandwala RA Effect of dietary lipid and vitamin E on mitochondrial lipid peroxidation and hepatic injury in the bile duct-ligated rat. J Lipid Res 1991, 32:1349-1357.
145. Sokol RJ, McKim JM, Goff MC, et al. Vitamin E reduces oxidant injury to mitochondria and the hepatotoxicity of taurochenodeoxycholic acid in the rat. Gastroenterology 1998, 114:164-174.
146. Sola R, Vila MC, Andreu M, et al. Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis: a randomized controlled study. J Hepatol 1994, 282-288.
147. Solis-Hernuzo JA, Gonzalez-Gamarra A, Castellano G, et al. Metabolic clearance rate of arginine vasopressin in patients with cirrhosis. Hepatology 1992, 16:974-979.
148. Standl T, Lipfert B, Reeker W, et al. Acute effects of complete blood exchanges with ultra-purified hemoglobin solution or hydroxyethyl starch on liver and kidney in the animal model. Anasthesiol Intensivemed Notfallmed Schmerzther 1996, 31:354-361.
149. Sterczer A, Meyer HP, Van Sluijs FJ, et al. Fast resolution of hypercortisolism in dogs with portosystemic encephalopathy after surgical shunt closure. Res Vet Sci 1999, 66:63-67.
150. Stoff JS Phosphate homeostasis and hypophosphatemia. Am J Med 1982, 72:489-495.
151. Stump DC, Strauss RG, Henriksen RA, et al. Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII. Transfusion 1985, 25:230-234.
152. Such J, Frances R, Munoz C, et al. Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites. Hepatology 2002, 36:135-141.
153. Symington BE Hetastarch and bleeding complications. Ann Intern Med 1986, 105:627-628.
154. Tanifuji Y, Kamide M, Shudo Y, et al. Clinical evaluation of acetated ringer as intraoperative fluids for patients with liver cirrhosis. Masui 1983, 32:1347-1352.
155. Tannen RL Relationship of renal ammonia production and potassium homeostasis. Kidney Int 1977, 11:453-465.
156. Tannen RL, Kunin AS Effect of pH on ammonia production by renal mitochondria. Am J Physiol 1976, 231:1631-1637.
157. Tannen RL Ammonia and acid base homeostasis. Med Clin North Am 1983, 67:781-798.
158. Terg R, Berreta J, Abecasis R, et al. Dextran administration avoids hemodynamic changes following paracentesis in cirrhotic patients. A safe and inexpensive option. Dig Dis Sci 1992, 37:79-83.
159. Terg R, Miguez CD, Castro L, et al. Pharmacokinetics of Dextran-70 in patients with cirrhosis and ascites undergoing therapeutic paracentesis. J Hepatol 1996, 25:329-333.
160. The SAFE Study Investigators A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004, 350:2247-2256.
161. Thompson WL, Fukushima T, Rutherford RB, et al. Intravascular persistence, tissue storage, and excretion of hydroxyethyl starch. Surg Gynecol Obstet 1970, 131:965-972.
162. Thompson WL, Gadsden RH Prolonged bleeding times and hypofibrinogenemia in dogs after infusion of hydroxyethyl starch and dextran. Transfusion 1965, 5:440-446.
163. Toulza O, Center SA, Brooks MB, et al. Protein C deficiency in dogs with liver disease. J Vet Int Med 2004, 18:445. (abstract).
164. Unikowsky B, Wexler MJ, Levy M Dogs with experimental cirrhosis of the liver but without intrahepatic hypertension do not retain sodium or form ascites. J Clin Invest 1983, 72:1594-1604.
165. Uriz J, Gines P, Cardenas A, et al. Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome. J Hepatol 2000, 33:43-48.
166. Vaamonde CA Renal water handling in liver disease. The kidney in liver disease 1988, 31-72. Williams & Wilkins, Baltimore. ed 3. M. Epstein (Ed.).
167. Vinay P, Cardoso M, Tejedor A, et al. Acetate metabolism during hemodialysis: metabolic considerations. Am J Nephrol 1987, 7:337-354.
168. Watanabe A, Matsuzaki S, Moriwaki H, et al. Problems in serum albumin measurement and clinical significance of albumin microheterogeneity in cirrhotics. Nutrition 2004, 20:351-357.
169. Weber P, Bendich A, Machlin LJ Vitamin E and human health: rationale for determining recommended intake levels. Nutrition 1997, 13:450-460.
170. Wilkes MM, Navickis RJ Patient survival after human albumin administration: a meta-analysis of randomized, controlled trials. Ann Intern Med 2001, 135:149-164.
171. Wong F, Blei AT, Blendis LM, et al. A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial. Hepatology 2003, 37:182-191.
172. Woods HF, Connor H, Tucker GT The role of altered lactate kinetics in the pathogenesis of type B lactic acidosis. Metabolic acidosis, CIBA Found Symp 1982, 87:307-323.
173. Yacobi A, Gibson TP, McEntegart CM, et al. Pharmacokinetics of high molecular weight hydroxyethyl starch in dogs. Res Comm Chem Pathol Pharmacol 1982, 36:199-204.
174. Yedgar S, Carew RE, Pittman RC, et al. Tissue sites of catabolism of albumin in rabbits. Am J Physiol 1983, 244:E101-E107.
175. Zavagli G, Ricci G, Bader G, et al. The importance of the highest normokalemia in the treatment of early hepatic encephalopathy. Miner Electrolyte Metab 1993, 19:362-367.
176. Zimmon DS, Oratz M, Kessler R, et al. Albumin to ascites. Demonstration of a direct pathway bypassing the systemic circulation. J Clin Invest 1969, 48:2074-2078.
177. Center SA, Harte J, Watrous D, et al. The clinical and metabolic effects of rapid weight loss in obese pet cats and the influence of supplemental oral l-carnitine. J Vet Intern Med 2000, 14:598-608.
178. Center SA, Sunvold GD Investigations of the effect of l-carnitine on weight reduction, body condition, and metabolism in obese dogs and cats. Recent advances in canine and feline nutrition, vol III, Iams Nutrition Symposium Proceedings 2000, 113-122. Orange Frazer Press, Wilmington, OH. G.A. Reinhart, D.P. Carey (Eds.).
179. Center SA, Warner KL, Erb HN Liver glutathione concentrations in dogs and cats with naturally occurring liver disease. Am J Vet Res 2002, 63:1187-1197.
180. Dawson DJ, Babbs C, Warnes TW, et al. Hypophosphataemia in acute liver failure. BMJ 1987, 295:1312-1313.
181. Guzman JA, Rosado AE, Kruse JA Vasopressin vs norepinephrine in endotoxic shock: systemic, renal, and splanchnic hemodynamic and oxygen transport effects. J Appl Physiol 2003, 95:803-809.
182. Heymsfield SB, Arteaga C, McManus C, et al. Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method. Am J Clin Nutr 1983, 37:478-494.
183. Nemec A, Pecar J, Seliskar A, et al. Assessment of acid-base status and plasma lactate concentrations in arterial, mixed venous, and portal blood from dogs during experimental hepatic blood inflow occlusion. Am J Vet Res 2003, 64:599-608.